Greater Cannabis Co. Files Q1 2025 10-Q

Ticker: GCAN · Form: 10-Q · Filed: May 12, 2025 · CIK: 1695473

Greater Cannabis Company, Inc. 10-Q Filing Summary
FieldDetail
CompanyGreater Cannabis Company, Inc. (GCAN)
Form Type10-Q
Filed DateMay 12, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, financials, cannabis-industry

TL;DR

Greater Cannabis Co. 10-Q filed. Q1 2025 financials out.

AI Summary

Greater Cannabis Company, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information for the first quarter of 2025, including comparative data from the first quarter of 2024. The company is involved in the pharmaceutical preparations industry, with its principal executive offices located in Baltimore, MD.

Why It Matters

This filing provides investors with the latest financial performance and operational details for Greater Cannabis Company, Inc. during the first quarter of 2025.

Risk Assessment

Risk Level: medium — As a publicly traded company filing a 10-Q, there are inherent risks associated with financial reporting and market performance.

Key Numbers

  • Q1 2025 — Reporting Period (Financials for the first quarter of 2025 are detailed.)
  • Q1 2024 — Comparative Period (Financials for the first quarter of 2024 are used for comparison.)

Key Players & Entities

  • Greater Cannabis Company, Inc. (company) — Filer of the 10-Q
  • 20250331 (date) — End of reporting period
  • 20250512 (date) — Filing date
  • 0001695473 (company) — Central Index Key for Greater Cannabis Company, Inc.
  • PHARMACEUTICAL PREPARATIONS [2834] (industry) — Standard Industrial Classification
  • BALTIMORE, MD (location) — Business and mailing address

FAQ

What is the primary business of Greater Cannabis Company, Inc.?

Greater Cannabis Company, Inc. is classified under the Standard Industrial Classification code 2834, which pertains to Pharmaceutical Preparations.

When was this 10-Q filing submitted to the SEC?

This 10-Q filing was submitted on May 12, 2025.

What is the fiscal year end for Greater Cannabis Company, Inc.?

The fiscal year end for Greater Cannabis Company, Inc. is December 31st.

Where are the principal executive offices of Greater Cannabis Company, Inc. located?

The principal executive offices are located at 15 Walker Ave, Suite 101, Baltimore, MD 21208.

What period does this 10-Q report cover?

This 10-Q report covers the period ending March 31, 2025.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 12, 2025 regarding Greater Cannabis Company, Inc. (GCAN).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.